| Inventor | Institute |
|---|---|
| Annemieke Aartsma-Rus | Leiden University and Leiden University Medical Center |
| SKU: | 154188 |
|---|---|
| Product description: | Duchenne muscular dystrophy (DMD) is a muscle-wasting disease in which muscle is continuously damaged, resulting in loss of muscle tissue and function. Antisense-mediated exon skipping is a promising therapeutic approach for DMD which uses sequence specific antisense oligonucleotides (AONs) to reframe disrupted dystrophin transcripts. As AONs function in a sequence specific manner, human specific AONs cannot be tested in the current mdx mouse model for DMD as it carries a mutation in the murine Dmd gene. In order to model the human disease more accurately we generated an ES mouse cell line carrying the complete human DMD gene integrated in the mouse genome on an mdx background. This cell line was used to generate the hDMD/mdx mouse (Cat No:154187) |
| Alternate name: | Dystrophin, Muscular Dystrophy, Duchenne And Becker Types, DXS164, DXS26, DXS23, DXS239, DXS268, DXS269, DXS27, DXS272 |
| Conditional: | No |
| Production details: | Blastocysts were isolated from time mated hDMD male mice and super ovulated mdx female mice. These blastocysts were layered on murine embryonic fibroblast (MEF) feeder cells in a well of a 24-well plate, in knockout DMEM supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate, non-essential amino acids, 50 units/ml of penicillin as well as streptomycin, 1000 units/ml of LIF) and 15% knockout serum replacement. Usually after 6 days blastocysts had hatched and a small colony of cells had forme… |
| Parental cell line: | Blastocysts were cultured to generate ES cell lines |
| Disease: | Duchenne muscular dystrophy |
| Cat. #: | 154188 |
|---|---|
| Unit size: | 1×10^6 cells / vial |
| Research Fields: | Cell biology; Drug development |
| Organism: | Human |
| Tissue: | Embryo |
| Model: | Stem Cells |
| Format: | Frozen |
|---|---|
| Shipping conditions: | Dry ice |
| Growth medium: | ES medium with 15% knock serum replacement, on MEF coated plates |
| References: |
Veltrop et al. 2013. PLoS Curr. 5:. PMID: 24057032 |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.